A lab performs O–6–methylguanine–DNA methyltransferase (MGMT) promoter methylation analysis, typically as a prognostic marker for responsiveness of glioblastoma (brain tumor) to alkylating chemotherapy using temozolomide.
For clinical responsibility, terminology, tips and additional info
start codify free trial.